Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot comparison of romosozumab and denosumab in rheumatoid arthritis patients with high fracture risk osteoporosis
jRCT1080224677Completed
- Sponsor
- Takeshi Mochizuki
- Start
- May 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Trial of romosozumab and denosumab in osteoporosis and rheumatoid arthritis (RA) (2 arms), sponsored by Takeshi Mochizuki. Started May 2019; status: completed.
02
Drugs
romosozumabdenosumab
03
Conditions
osteoporosisrheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT1080224677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224677.